retatrutide phase 2 trial results weight loss New 3 obesity trials came out and the are impressive: - 1,152 patients with obesity & type diabetes retatrutide weight loss phase 2

Compounded versions may have slightly different viscosity than the brand-name product, which can affect how the injection feels at different sites

Cells or islets were fixed at room temperature for 20 minutes in 2% PFA + 2% glutaraldehyde in 0.1 M sodium cacodylate, washed 2x with 0.1 M sodium cacodylate and 1x with ddH 2 O, and then post-stained on ice with 2% osmium tetroxide for 1 hour followed by 1% tannic acid at room temperature for 45 minutes, and washed 2x in 0.05 M sodium cacodylate before stepwise dehydration in 70%, 90%, and 100% EtOH and Epon resin embedding

Hair loss concerns have emerged in community discussions, though clinical trial data did not identify this as a statistically significant adverse event

Hypoglycemia Glucose deficiency probably sounds like a predictable side effect from a drug that reduce glucagon secretion, but for most patients, its actually a self-terminating effect

If you don't adjust your dose under the guidance of a GP, you might end up with too much hormone in your system, leading to hyperthyroid symptoms like a racing heart or anxiety

Intracellular hydrogen peroxide (H2O2) detection To detect the intracellular H 2 O 2 content, 143B cells were incubated with PBS, Ru(II)-OH, NP2, and NP4 (Ru 10 M) for 6 h